|
Market Closed -
Euronext Paris
18:55:00 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.790 EUR | -1.30% |
|
-10.30% | +77.10% |
| 09-02 | THX Pharma Partnership Seeks Regulatory Clearance for Late-stage Juvenile Batten Disease Drug Trial | MT |
| 07-09 | THX Pharma secures its financial roadmap |  |
| Market Cap | 52.29M 60.77M 49.2M 44.94M 84.07M 5.74B 84.3M 581M 226M 2.94B 228M 223M 9.48B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 28.59M 33.22M 26.9M 24.57M 45.97M 3.14B 46.09M 318M 123M 1.61B 125M 122M 5.18B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.97% | Yield 2026 * |
-
| Yield 2027 * | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALTHX | Real-time | |
CBOE
| Real-time | ||
|
Börse Stuttgart
| 3VG | Delayed | |
|
Deutsche Boerse AG
| 3VG | Delayed | |
|
Boerse Muenchen
| 3VG | Real-time | |
|
CBOE
| Real-time |
| 1 day | -1.30% | ||
| 1 week | -10.30% | ||
| Current month | -8.34% | ||
| 1 month | -16.15% | ||
| 3 months | +16.62% | ||
| 6 months | +21.09% | ||
| Current year | +77.10% |
| 1 week | 3.72 |  | 4.39 |
| 1 month | 3.72 | | 4.75 |
| Current year | 1.83 | | 5.1 |
| 1 year | 1.49 | | 5.1 |
| 3 years | 0.26 | | 5.1 |
| 5 years | 0.26 | | 9.16 |
| 10 years | 0.26 | | 23.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/01/2023 | |
Christine Placet
DFI | Director of Finance/CFO | - | 01/04/2024 |
Marie Sebille
CTO | Chief Tech/Sci/R&D Officer | - | 19/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/03/2024 | |
| Chairman | - | 31/03/2024 | |
Julien Veys
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/3/26 A | Buy | Chief Operating Officer | 2,825 | 0.0195% | ||
| 4/3/26 A | Buy | Chief Operating Officer | 4,488 | 0.0310% | ||
| 4/3/26 A | Sell | Chief Operating Officer | 4,944 | 0.0342% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.30% | -10.30% | +50.40% | +204.17% | 60.77M | |
| -1.79% | -2.27% | +50.90% | +89.03% | 67.98B | |
| -2.06% | -0.18% | +41.53% | +88.17% | 64.94B | |
| -0.31% | +6.54% | -11.39% | +457.82% | 27.58B | |
| -3.00% | -2.90% | +39.40% | +9.41% | 25.74B | |
| +0.86% | +1.65% | +0.25% | -14.78% | 26.06B | |
| -1.46% | +0.42% | +24.07% | -18.70% | 20.09B | |
| -2.96% | -15.21% | +210.71% | +370.84% | 17.16B | |
| -1.49% | -4.88% | -0.41% | +530.26% | 14.92B | |
| -0.20% | +8.37% | +57.87% | +159.50% | 14.62B | |
| Average | -1.37% | -0.80% | +46.33% | +187.57% | 27.92B | |
| Weighted average by Cap. | -1.52% | +0.17% | +42.29% | +145.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 11.9M 13.83M 11.2M 10.23M 19.13M 1.31B 19.19M 132M 51.34M 670M 51.93M 50.8M 2.16B | 4.3M 5M 4.05M 3.7M 6.91M 472M 6.93M 47.81M 18.55M 242M 18.76M 18.36M 780M |
| Net Debt | -23.7M -27.54M -22.3M -20.37M -38.11M -2.6B -38.21M -263M -102M -1.33B -103M -101M -4.3B | -27.4M -31.84M -25.78M -23.55M -44.05M -3.01B -44.17M -305M -118M -1.54B -120M -117M -4.97B |
Employees
12
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | €3.790 | -1.30% | 74,215 |
| 03/09/26 | €3.840 | -7.02% | 211,065 |
| 02/09/26 | €4.130 | +0.73% | 196,552 |
| 01/09/26 | €4.100 | -0.85% | 38,377 |
| 31/08/26 | €4.135 | -2.13% | 43,882 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.790EUR
Average target price
5.800EUR
Spread / Average Target
+53.03%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHX Stock
Select your edition
All financial news and data tailored to specific country editions
